YS110 - CAS 1656248-21-3

YS110 is a humanized anti-CD26 (DPP4) IgG1 monoclonal antibody. It induces CD26 nuclear translocation via the caveolin pathway and inhibits tumor cell proliferation by delaying the G2/M cell cycle transition. Additionally, YS110 blocks the binding of MERS CoV S1 to CD26, thereby preventing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. This compound is applicable in research on cancer and infections, including malignant mesothelioma and MERS.

P38 MAPK, Proteasome, ERK

Proteases/Proteasome, MAPK, Ubiquitination

1656248-21-3

-20°C

Ice Packs

Inhibitory Antibodies